Postoperative fibrosis is a natural consequence of surgical wound healing. The source of fibrotic tissue after spinal surgery was originally thought to arise from the disrupted intervertebral disc, 1 but a later study by Larocca and Macnab revealed that fibroblasts arose from the disrupted epaxial muscles in the surgical wound. 2 Postoperative peridural adhesion results in tethering, traction, and compression of the thecal sac and nerve roots causing a recurrence of hyperesthesia that typically manifests a few months after laminectomy surgery. [3] [4] [5] [6] [7] [8] [9] Although controversy exists about the role of peridural fibrosis in failed back surgery syndrome, 10, 11 it is accepted by many to be a problematic clinical entity with no efficacious treatment options. 3, 5, 6, [12] [13] [14] [15] [16] [17] [18] The advent of Gadolinium DPTA-contrasted magnetic resonance imaging (MRI) has resulted in easier identification of recurrent intervertebral disc extrusion versus peridural scarring as a cause of failed back surgery syndrome. 17, 19, 20 Reoperation for removal of scar tissue is associated with poor outcome results and increased risk of injury due to the difficulty of identifying neural structures that are surrounded by scar tissue. 8, 9, 16, 18, 19, 21 Therefore, experimental and clinical studies have primarily focused on preventing the adhesion of scar tissue to the dura and nerve roots.
The putative ideal agent for preventing peridural adhesion and fibrosis would have the following properties: (1) prevention of scar tissue adhesion to the dural tissues, (2) prevention of the development of leptomeningeal arachnoiditis, (3) lack the potential to impair dural healing following tear and cerebrospinal fluid leakage, and (4) lack the capability to induce excessive inflammation around neural tissues. Previously studied materials or techniques include autografts (free and pedicled fat grafts, ligamentum flavum, lamina replacement), [22] [23] [24] [25] [26] [27] [28] [29] manufactured biomaterials that provide a mechanical barrier (e.g., expanded polytetrafluoroethylene membrane, Gel Foam, silastic membrane, Surgicel, Avitene, polymethylmethacrylate, TachoComb, synthetic carbo-hydrate polymers, and Gortex), 5,18,25,26,30 -37 topical administration of biochemicals to reduce fibroblast function and infiltration (e.g., urokinase, tissue plasminogen activator, mitomycin-C, hylaronic acid, glucocorticoids), 4,9,38 -40 and intraoperative application of CO 2 laser therapy or localized administration of external beam radiation perioperatively. [41] [42] [43] The efficacy and safety of each of these agents and techniques have not met with widespread acceptance. Use of free fat autografts as an interposition membrane is probably the most common practice in human spinal surgery, but some reports have shown little benefit or even detrimental results due to herniation of the fat graft with subsequent neural impingement. 22, 24, 27, 28, 33, 44 Previously, studies suggested the most statistically and consistently effective antiadhesion barrier used in spinal surgery was ADCON-L. 8, 10, 17, [45] [46] [47] [48] [49] [50] [51] [52] However, ADCON-L was removed from the market following multiple reports implicating the product in impaired dural healing and persistent cerebrospinal fluid leakage following unrecognized dural tear in people, despite experimental work in rats that suggested it would not impair dural healing. [53] [54] [55] Postmortem evaluations of the treated and control laminectomy segments included blinded gross ratings of the tenacity and volume of the peridural scar by 3 observers in 7 sheep and histologic analysis in 4 sheep.
Preliminary studies in a rat model demonstrated significant reduction of peridural scarring with the use of a polylactide resorbable film. 56 A study by Welch et al 37 evaluated the use of a 0.02-mm-thick polylactide resorbable membrane as a mechanical antiadhesion barrier in dog and ovine small laminotomy models. In this study, good results were obtained with the film as a barrier membrane to peridural fibrosis. Results of a subsequent study by Klopp et al 57 to evaluate the efficacy of the same barrier film in a more challenging complete dorsal (posterior) laminectomy and durotomy model in the ovine species revealed similar benefits.
In the present study, the efficacy of 2 bioresorbable/ biocompatible polylactide membranes (a 20 m thick Lactosorb (L20) and a 40 m thick Lactosorb (L40), specific composition: 88% PLA/12% PGA; Biomet Osteobiologics, Parsippany, NJ) and Mesofol (M), a 40 m thick, caprolactone/lactide, bioresorbable/biocompatible barrier (Biomet Europe) were evaluated in a 3-level complete dorsal laminectomy model. Premortem myelographic studies were performed in all sheep and MRI studies were performed in 4 sheep to evaluate for evidence of cerebrospinal fluid leakage and scar formation. Postmortem evaluations included blinded gross ratings of the tenacity and scar volume of the peridural scar by 3 observers and histologic studies of the treated and control laminectomy segments in 7 sheep and histologic analysis in 5 sheep.
Materials and Methods

Animal Subjects
Eleven skeletally mature, female, Rambouillet-Columbian cross sheep were used in this study.
Anesthesia and Pain Management
Ear vein catheters were placed for intravenous medication and fluid administration. The sheep were sedated with 7.5 mg of diazepam IV (Hospira Inc., Lake Forest, IL) and 4 mg/kg of ketamine IV (Ketavet, IVX Animal Health Inc., St. Joseph, MO) and anesthesia was maintained with isoflurane at 1.5% to 3% in 100% oxygen at 2 L/min (IsoFlo, Abbott Laboratories, North Chicago, IL). The sheep were given 15 mg/kg of atracurium IV (Mayne Pharma Inc., Paramus, NJ) intraoperatively to facilitate muscle dissection and retraction. Respiration was controlled with a mechanical ventilator to maintain normocapnia and adequate oxygenation.
Fentanyl patches (5 mg and 10 mg) (Mylan Laboratories Inc., Morgantown, WV) were applied 24 hours before surgery and maintained for 3 days. In addition, phenylbutazone 1 g PO (VetOne, Bimeda Inc., LeSueur, MN) was administered daily from 1 day preoperative to 3 days after surgery. Before skin incision, 8 mL of lidocaine 2% (Hospira Inc., Lake Forest, IL) was injected into the subcutaneous tissues along the length of the incision site and 8 mL per side of bupivicaine 0.75% (Hospira Inc.) was injected into the epaxial muscles bilaterally before skin closure.
Test Materials
Three bioresorbable products were evaluated as a barrier to postoperative peridural adhesion: (1) 
Ovine Laminectomy Model
The wool was clipped and the sheep were aseptically prepared for dorsal (posterior) approach to the T13, L2, and L4 vertebral laminae. A midline incision was made into the skin and subcutaneous tissues from T12 to L5. The fascia thoracolumbalis and semispinalis, multifidi and longissimus lumborum muscles were elevated from the dorsal spinous processes, laminae, and pedicles from the dorsal (posterior) aspect of T13, L2, and L4 bilaterally using subperiosteal elevation and electrocautery and leaving the intervening dorsal spinous processes and laminae intact. The dorsal spinous processes were removed from T13, L2, and L4 by drilling through its base and detached with bone rongeurs. Using a compressed air drill and bur, dorsal laminectomies were performed en bloc that extended between adjacent interarcuate spaces cranially and caudally and just medial to the articular facet joints bilaterally. The articular facet joints were left intact (Figure 1 ).
Once the laminectomies were completed, the intervertebral discs of T13-L1, L2-L3, and L4 -L5 were incised and the nucleus pulposus was disrupted with an 18-gauge needle. An incision made into the dura and subarachnoid space (durotomy) by an 18-gauge needle and was considered complete when cerebrospinal fluid was observed leaking outside the dura ( Figure  2 ). Test material was placed over 2 laminectomy defects leaving 1 defect as an untreated control site in each sheep. Each barrier film product was cut to approximate the shape of the laminectomy, but was 10% to 20% larger in size. The film barriers were inserted into the laminectomy site over the top of the dura and under the laminar bone ( Figure 3 ). The control site was left uncovered. Treatments were randomized among levels and test materials for all sheep. The thoracolumbar fascia, subcutaneous tissue, and skin were closed in a routine manner.
Analyses of Postoperative Healing
Myelography and MRI. At 10 weeks, the sheep were anesthetized by the same protocol used for the surgical procedure. Four sheep 8 -11 underwent MRI studies. All imaging was performed with a 1.5 T GE Sigma MRI instrument using a standard phase array spinal coil T2-weighted images were acquired in sagittal Myelography was performed in all 12 sheep. A cisternal cerebrospinal fluid tap was performed with a 20 g, 1.5Љ needle and 30 mL of iodinated contrast mixed with 5 mL of New Methylene Blue dye was injected into the cerebellomedullary cistern. New Methylene Blue dye was added to the contrast to allow visual observation of leakage at the dural incision site postmortem. The sheep were then positioned in a sitting position for 5 minutes to allow the contrast material to flow into the lumbar spine. Lateral and ventrodorsal postcontrast radiographs were taken that included both laminectomy sites and evaluated contrast leakage and for contrast column change or lack of cerebrospinal fluid contrast flow at the laminectomy sites. The sheep were killed (Pentobarbital 400 mg/mL; 20 mL) following myelogram.
Postmortem Gross Observations.
Immediately after euthanasia, postmortem examination was performed to evaluate the gross extent of peridural fibrosis in 7 sheep. The spines were removed en bloc from T12 to L5. The epaxial musculature was sharply dissected from the lateral and ventral aspects of the vertebrae. The musculature and postoperative fibrous tissue over the laminectomy site were left unaltered. The transverse processes were removed from the vertebral bodies with a bone rongeur and, using a band saw, the vertebral bodies were in- cised along the length of the column just ventrally (anteriorly) to the spinal canal leaving a thin edge of bone covering the ventral (anterior) spinal cord. The remaining bone was removed with a bone rongeur to expose the spinal cord in situ. The spinal cord was slowly elevated and dissected from the spinal canal in a ventral (anterior) direction and adhesion of the dorsal (posterior) dura and spinal cord at the laminectomy sites were evaluated by the dissector (AST) and 1 observer (BJS), both of whom were blinded to the treatment sites. (Figure 4 ) The dissection was also videotaped for evaluations by another blinded evaluator (LSK). Scarring at the operative sites was analyzed and graded by volume (extent) and the tenacity (severity) of adhesion to the dura.
Histologic Evaluation of Healing. Histologic evaluation was performed on 5 of the sheep spines. Specimens were placed in 10% buffered formalin for a period of 30 days under vacuum to fix the tissues. This was followed by dehydration in increasing concentrations of ETOH under vacuum with gentle agitation for 6 weeks. Acetone was used to remove any fatty tissue and prepare the specimens for Spurrs infiltration. The specimens were then placed in 1:1 ratio of Spurr plastic and acetone under vacuum with gentle agitation and rotated daily. After 10 days, the spines were allowed to stay in 100% Spurr plastic under vacuum and gentle agitation for 1 week. Finally, specimens were cured in 60°C oven under vacuum for 24 hours.
Embedded spines were sectioned in the transverse plane using an Isomet 5000 Saw (Buehler Ltd., Lake Bluff, IL) and ground to 75 m using the EXAKT Grinding System (EXAKT Medical Instruments, Inc., OK). Sections were then stained using hematoxylin and eosin.
Results
Handling Characteristics of the Bioresorbable Film Products
All barrier films were smooth and displayed a "plasticlike" appearance and feel. Handling characteristics of the barrier determined by ease of configuring and placement into the laminectomy site was subjectively evaluated by the surgeon (L.S.K.). L20 and Mesofol were felt to be superior in handling and compatible with clinical usage. L40 was thicker and found to be more difficult to manipulate without inducing creasing and sharp edges.
Clinical Evaluation of the Sheep After Surgery
Neurologic deficits were not observed in any of the sheep during the duration of the study.
Myelography and Magnetic Resonance Imaging
Summaries of myelographic and MRI studies are found in Tables 1 and 2, respectively. An example of MRI findings is found in Figure 5 .
Gross Dissection Observations
Both evaluators (B.J.S., A.S.T.) of gross dissection were blinded to the treatment and control sites. Each laminectomy site (treatment and control) was graded by the evaluators. One evaluator (L.S.K.) scored the scar tenacity and scar volume at a later time by reviewing a videotape taken at postmortem examination. Leakage of New Methylene Blue dye from the durotomy sites was not observed in any of the sheep.
Volume of scar adhesion was assigned grades ranging from 0 to 4. The parameters defining each score value can be found with Table 3 . Tenacity of scarring was also assigned a grade ranging from 0 to 4. The parameters defining each score value can be found with Table 4 . Results from each individual evaluator and mean scores are presented in Tables 3 and 4 . Averaged total scores for each product are presented in Figures 6 and 7 . Scores for scar tenacity at the treated sites ranged from 0 to 4 for L20, from 0 to 3 for L40 and from 1 to 3 for Mesofol and ranged from 1 to 4 for untreated control sites (Table 3) . Average scores for tenacity were 1.5 for L20, 1.67 for L40 and 1.0 for Mesofol in comparison to the average scar tenacity score of 2.81 for control sites ( Figure 6 ). Scores for scar volume at the treated sites ranged from 0 to 2 for L20, from 0 to 4 for L40 and from 0 to 1 for Mesofol (Table 1 ) and ranged from 1 to 4 for untreated control sites. Averaged scores for scar volume were 1.56 for L20, 1.67 for L40 and 0.93 for Mesofol in comparison to the average scar volume score of 2.67 for control sites ( Figure 6 ). Significance scores for volume and tenacity included overall comparisons between the treatment groups: control, L20, L40 and Mesofol. The significance differences were assessed using a restricted maximum likelihood-based mixed-effect model that included the categorical, fixed effects of treatment, spinal level, and observer. A random animal effect was also included in the model via PROC MIXED in SAS. Scorer, animal, and spinal level did not have significant effects on scar tenacity and or volume. Significant differences were found for all treatments in comparison to control with P values Ͻ0.05 for both scar tenacity and volume. There were no 
T2-W:
Within normal limits on sagittal images; anatomical detail is maintained but there is dorsal tenting of the dura and subarachnoid spaces on transverse images T1-W Precontrast: Within normal limits on sagittal images; loss of anatomical detail and extension of the scar tissue into the laminectomy site and left laterally T1-W Postcontrast: Within normal limits on sagittal images; scar tissue enhances and extends into the laminectomy site but the subarachnoid space is delineated from the scar tissue on transverse images Spinal level: L2 Treatment: Control
Within normal limits on sagittal images; dura and subarachnoid space remain well-delineated on transverse images T1-W Precontrast: Within normal limits on sagittal images; the dura and subarachnoid space remain well-delineated on transverse images T1-W Postcontrast: Within normal limits on sagittal images; scar tissue enhances, but the dura and subarachnoid space remain well-delineated from the scar tissue on transverse images Spinal level: L4 Treatment: L40
Mild disruption of the dorsal subarachnoid space on sagittal images; the dura and subarachnoid space remain welldelineated on transverse images T1-W Precontrast: Within normal limits on sagittal images; dura and subarachnoid space remain well-delineated on transverse images T1-W Postcontrast: Within normal limits on sagittal images; scar tissue enhances, but the dura and subarachnoid space remain well-delineated from the scar tissue on transverse images 11
Spinal level: T12 Treatment: Mesofol T2-W: within normal limits on sagittal images; subarachnoid space seems compressed and in one image the dural tissues seem dorsally tented on transverse images T1-W Precontrast: Within normal limits on sagittal images; scar tissue extends into the laminectomy defect, some loss of anatomical detail and delineation of the subarachnoid space midlaminectomy but otherwise anatomical detail on transverse images T1-W Postcontrast: Within normal limits on sagittal images; scar tissue enhances and extends into laminectomy defect disrupting the anatomical detail dorsally and laterally around the spinal cord on transverse images Spinal level: L1 Treatment: Control
Within normal limits on sagittal images; dura and subarachnoid space remain well-delineated on transverse images T1-W Precontrast: Within normal limits on sagittal images; the dura and subarachnoid space remains well-delineated on transverse images T1-W Postcontrast: Within normal limits on sagittal images; scar tissue enhances but, the dura and subarachnoid space remain well-delineated from the scar tissue on transverse images Spinal level: L3 Treatment: L20
Within normal limits on sagittal images; dura and subarachnoid space remain well-delineated on transverse images T1-W Precontrast: Within normal limits on sagittal images; the dura and subarachnoid space remains well-delineated on transverse images T1-W Postcontrast: Within normal limits on sagittal images; scar tissue enhance, but the dura and subarachnoid space remain well-delineated from the scar tissue on transverse images significant differences when comparing treatments to each other; however, Mesofol treatment showed the lowest average volume and tenacity scores.
Histologic Analyses Treated and control laminectomy sites were evaluated histologically in 4 sheep. Inflammation was not observed in any of the laminectomy sites. Adhesion of scar tissue to the dura was noted primarily in the untreated control site in all sheep. In 1 site, minimal adhesion was observed in only 1 side of 1 site in a laminectomy treated with Mesofol.
Discussion
Bioresorbable polylactide film barriers are currently used in surgical scenarios to reinforce soft tissue, for temporary wound support, and to minimize soft tissue attachments in the viscera. Previous studies have documented the biocompatibility of the polylactide film with both peripheral and spinal cord nervous tissue. 37, 37, 57, [57] [58] [59] [60] [61] [62] It has been postulated that the encapsulated polylactide film may act as a surgical dissection plane, whereby the layer of organized fibrous tissue enveloping the material forms a controlled, distinguishable dissection plane allowing adjacent tissues to be easily separated. 37, 57 Mesofol, a newer caprolactone/lactide material, is a transparent, bioresorbable, and biocompatible material that can be inserted between muscles, tendons, or nerves to prevent postoperative adhesion due to scar formation around these anatomic structures. In in vitro testing, Mesofol has been shown to be impermeable to microorganisms and large molecules until degradation of the product begins, which occurs at a time later than that associated with the development of adhesions. Preclinical investigations indicate a degradation period of 4 to 6 weeks both in vitro and in vivo. Indeed, residual film was not observed in histologic specimens in this 10 week in vivo ovine study. The film has a thickness of 40 m and becomes soft and flexible at a temperature of 25°C, allowing it to be easily configured to tissues to be separated. If anatomic conditions do not allow suitable fixation, it can be sutured in place with resorbable suture materials. Our present findings suggest that in an ovine total laminectomy model, both the polylactide film (Lactosorb) and the newer caprolactone/lactide film (Mesofol) seem to decrease both the tenacity and volume of the peridural adhesions. This is further supported by histologic analysis, which shows decreased fibrous tissue attachments on the dural surface in the presence of polymer barrier. These findings further support what the prior studies have reported to date for smaller animals as well as smaller surgical sites (laminotomies). 41, 61 Although the current study suggests a trend toward better prevention of dural adhesions with use of Mesofol versus the Lactosorb materials, the small number of animals did not result in statistical significance between the products.
Compromised dural healing or cerebrospinal fluid leaks were not identified with any of the test products in the animals using myelographic evaluation, MRI, and visual dye inspection at 10 weeks. This is significant because of concerns raised with use of ADCON-L (a spinal product no longer on the market) suggesting that impaired healing and persistent cerebrospinal fluid leakage occurred 39, 53 after unrecognized dural tear and product placement in the spine. Prior animal studies have suggested the polylactide film to be effective in reducing the volume and tenacity of peridural adhesions immediate adjacent to the dural surface. 18, 37, 56, 57 Histology did not reveal adhesions identified on MRI or during the gross evaluation. The authors believe this may have been related to the processing of the samples as the soft tissue were significantly shrunken and adhesions tended to be much less tenacious than those in the control sites.
In conclusion, the results of this study suggest that Mesofol is compatible with clinical usage and beneficial for use as a postoperative antiadhesion barrier in neuro- 
Key Points
• Post operative scarring is a natural healing response but may have negative consequences when associated with spinal surgery and may play a role in "failed back" syndrome.
• Many biocompatible treatments and autografts have been studied in effort deter peridural fibrosis after surgery with variable experimental and clinical efficacy.
• Antiadhesion treatments must adequately prevent adhesion to the spinal cord but not interfere with healing of unrecognized dural tears that may occur intraoperatively.
• The polylactide and lactide/caprolactone barriers used in this study display efficacy and safety in use for prevention of postoperative adhesions and peridural fibrosis.
